Human EGFR/ERBB1/HER1 HEK293T Stable Cell Line

Introduction

The Human EGFR/ERBB1/HER1 HEK293T Stable Cell Line is a valuable tool for studying the structure, activity, and potential therapeutic applications of the human epidermal growth factor receptor (EGFR). This stable cell line is derived from the HEK293T cell line, which is a widely used human embryonic kidney cell line that is known for its high transfection efficiency and ability to produce large amounts of recombinant proteins. The stable expression of EGFR in this cell line allows for consistent and reliable results in various experimental settings.

Structure of Human EGFR

EGFR, also known as ERBB1 or HER1, is a transmembrane receptor protein that belongs to the ERBB family of receptor tyrosine kinases. It is composed of an extracellular domain, a transmembrane domain, and an intracellular domain. The extracellular domain contains a ligand binding site, while the intracellular domain has a tyrosine kinase activity responsible for downstream signaling. EGFR is activated by binding to its ligands, such as epidermal growth factor (EGF) and transforming growth factor alpha (TGF-α), which leads to dimerization and activation of its tyrosine kinase activity.

Activity of Human EGFR/ERBB1/HER1 HEK293T Stable Cell Line

The stable expression of EGFR in the HEK293T cell line allows for the study of its activity in a controlled and reproducible manner. This cell line has been extensively used in various studies to investigate the downstream signaling pathways of EGFR, including the activation of the PI3K/AKT and MAPK/ERK pathways. In addition, the HEK293T cell line has been used to study the effects of different ligands on EGFR activation and downstream signaling. The stable expression of EGFR in this cell line ensures consistent and reliable results, making it an ideal tool for studying the activity of EGFR.

Application as a Therapeutic Target

EGFR has been identified as a potential therapeutic target in various types of cancer, including lung, breast, and colorectal cancer. The overexpression or mutation of EGFR is associated with increased cell proliferation, survival, and metastasis. Therefore, inhibiting EGFR activity has been a major focus in the development of targeted cancer therapies. The Human EGFR/ERBB1/HER1 HEK293T Stable Cell Line can be used to screen and evaluate the efficacy of potential EGFR inhibitors in vitro. This allows for the identification of novel therapeutics that can specifically target EGFR and potentially improve cancer treatment.

Utilization of Flow Cytometry

Flow cytometry is a widely used technique for analyzing and quantifying various cellular parameters, such as cell surface markers, cell cycle progression, and protein expression. The Human EGFR/ERBB1/HER1 HEK293T Stable Cell Line can be used in flow cytometry experiments to investigate the expression and activation of EGFR. This allows for the characterization of the cell line and the evaluation of its response to different ligands and inhibitors. Flow cytometry also enables the isolation of specific cell populations for further analysis, such as downstream signaling pathways or gene expression.

Conclusion

In summary, the Human EGFR/ERBB1/HER1 HEK293T Stable Cell Line is a valuable tool for studying the structure, activity, and potential therapeutic applications of EGFR. Its stable expression in the HEK293T cell line ensures consistent and reliable results, making it an ideal model for investigating EGFR signaling and its role in cancer. The use of flow cytometry further enhances the versatility of this cell line and allows for a more comprehensive understanding of EGFR biology. Overall, this stable cell line is a valuable resource for researchers studying EGFR and its potential as a therapeutic target.